SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-053721
Filing Date
2021-08-27
Accepted
2021-08-27 18:43:35
Documents
2
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9252
2 POA DOCUMENT poa.txt EX-24.4_1006115 4684
  Complete submission text file 0001209191-21-053721.txt   15433
Mailing Address 1 TOWER PLACE, SUITE 850 C/O APPLIED MOLECULAR TRANSPORT INC. SOUTH SAN FRANCISCO CA 94080
Business Address
Bhatt Elizabeth (Reporting) CIK: 0001748622 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 211220464

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations